Thomas Vanassche
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Venous Thromboembolism Diagnosis and Management 62
-
- Atrial Fibrillation Management and Outcomes 32
- Antiplatelet Therapy and Cardiovascular Diseases 10
- Co-authors
- Peter B. Verhamme (105 shared papers)Laurens Liesenborghs (15 shared papers)Marijke Peetermans (18 shared papers)Christophe Vandenbriele (28 shared papers)Marc Hoylaerts (19 shared papers)John W. Eikelboom (14 shared papers)Willy E. Peetermans (9 shared papers)Olaf Schneewind (7 shared papers)
- Journals
- Journal of Thrombosis and Haemostasis (22 papers)European Heart Journal (11 papers)Research and Practice in Thrombosis and Haemostasis (10 papers)Thrombosis and Haemostasis (9 papers)Atherosclerosis (6 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Thomas Vanassche
203 papers receiving 6.4k citations
Thomas Vanassche's Hit Papers
Peers
Comparison fields: 5 of 107
- Internal Medicine 1.2k
- Cardiology and Cardiovascular Medicine 2.7k
- Hematology 702
- Infectious Diseases 505
- Genetics 215
Countries citing papers authored by Thomas Vanassche
This map shows the geographic impact of Thomas Vanassche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Vanassche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Vanassche more than expected).
Fields of papers citing papers by Thomas Vanassche
This network shows the impact of papers produced by Thomas Vanassche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Vanassche. The network helps show where Thomas Vanassche may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Vanassche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation Hit paper breakdown → | 2021 | 787 |
| 2 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 679 |
| 3 | Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Hit paper breakdown → | 2019 | 360 |
| 4 | 2014 | 252 | |
| 5 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 249 |
| 6 | Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial Hit paper breakdown → | 2022 | 176 |
| 7 | 2022 | 123 | |
| 8 | 2016 | 112 | |
| 9 | 2017 | 105 | |
| 10 | 2014 | 101 | |
| 11 | 2019 | 92 | |
| 12 | 2015 | 86 | |
| 13 | 2020 | 86 | |
| 14 | 2017 | 76 | |
| 15 | 2021 | 76 | |
| 16 | 2014 | 74 | |
| 17 | 2017 | 72 | |
| 18 | 2022 | 72 | |
| 19 | 2021 | 71 | |
| 20 | 2014 | 65 |
About Thomas Vanassche
Thomas Vanassche is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Infectious Diseases and Epidemiology, having authored 224 papers that have together received 6.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (62 papers), Atrial Fibrillation Management and Outcomes (32 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers), Infective Endocarditis Diagnosis and Management (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Platelet Disorders and Treatments (10 papers) and Lipoproteins and Cardiovascular Health (9 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Cardiology and Cardiovascular Medicine (2.7k citations), Hematology (702 citations), Infectious Diseases (505 citations) and Genetics (215 citations). Thomas Vanassche has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Peter B. Verhamme, Laurens Liesenborghs, Marijke Peetermans, Christophe Vandenbriele, Marc Hoylaerts, John W. Eikelboom, Willy E. Peetermans, Olaf Schneewind, Stuart J. Connolly and Jorien Claes. Their work appears in journals such as Journal of Thrombosis and Haemostasis, European Heart Journal, Research and Practice in Thrombosis and Haemostasis, Thrombosis and Haemostasis and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.